Neoplasia/BPH

	[(177)Lu]Lu-PSMA radioligand therapy in systemic therapy-naÃ¯ve metastatic hormone-sensitive prostate cancer patients: a retrospective study. Eur J Nucl Med Mol Imaging Langrate IK, Ofner H, Kretschmer-Chott E, Einspieler H, Kulterer OC, Schmitl S, Nics L, Shariat SF, Hacker M, Rasul S, Kramer G. PMID: 41680477 [PubMed - as supplied by publisher]
	Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis Morgans AK, Wallis CJD, Halabi S, Armstrong AJ, Adorjan P, Ghadessi M, Verholen F, Grimm MO. PMID: 41680329 [PubMed - as supplied by publisher]
	Re: Optimal Duration of Androgen Deprivation Therapy with Definitive Radiotherapy for Localized Prostate Cancer. A Meta-analysis. Eur Urol Viti A, Scuderi S, Briganti A, Gandaglia G, Montorsi F. PMID: 41680056 [PubMed - as supplied by publisher]
	Biochemical Recurrence-Free Survival After Radical Prostatectomy in Patients with High-Risk Prostate Cancer: A Nationwide Study of PSMA PET/CT Versus Conventional Imaging. J Nucl Med Mogensen AW, Torp-Pedersen C, Nørgaard M, Petersen LJ, Østergren PB, Zacho HD. PMID: 41679924 [PubMed - as supplied by publisher]
	Phase 2 Prospective Trial of Retreatment with [(177)Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA. J Nucl Med Nikitas J, Holzgreve A, Juarez J, Kimura K, Lira S, Alam H, Contreras M, Theus L, Nguyen AT, Ells Z, Zhu S, Grogan T, Elashoff DA, Unterrainer LM, Dahlbom M, Allen-Auerbach M, Czernin J, Calais J. PMID: 41679923 [PubMed - as supplied by publisher]
	Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Fizazi K, Attard G, Azad AA, Baciarello G, Beltran H, Bjartell A, Blanchard P, Bossaert F, Castro E, Compérat E, de Bono J, Deschamps A, Efstathiou E, Emmett L, Fanti S, Fonteyne V, González-Del-Alba A, Gravis G, James ND, Kanesvaran R, McDermott RS, Mehra N, Parker C, Renard-Penna RM, Rubin MA, Saad F, Sweeney C, Tilki D, Tombal B, Tree AC, Walz J, Zilli T, Gillessen S, ESMO Guidelines Committee. PMID: 41679466 [PubMed - as supplied by publisher]
	Analysis of bladder cancer therapeutic drug clinical trials in mainland China and globally. Biochim Biophys Acta Rev Cancer Kuang J, An Y, Zhang X, He Z, He J, Zhang Y, Sun F, Chen K. PMID: 41679353 [PubMed - as supplied by publisher]
	Association between Photodynamic diagnosis and risk of recurrence and progression in BCG-treated non-muscle invasive bladder cancer patients: a nationwide follow-up study. Urology Hjort PB, Hyldgaard JM, Young-Halvorsen K, Hüsch T, Jensen JB, Ernst A. PMID: 41679343 [PubMed - as supplied by publisher]
	Pain Perception During Transperineal and Transrectal Prostate Biopsy Under Local An-esthesia: a Prospective Analysis of a Multi-ethnic and Diverse Cohort. Int Braz J Urol Chua KJ, Ramacciotti LS, Kaneko M, Inoue Y, Navarro LM, Cai J, Aron M, Halteh P, Kau E, Schuckman A, Hemal S, Desai M, Djaladat H, Gill IS, Aron M, Abreu AL. PMID: 41678707 [PubMed - indexed for MEDLINE]
	Application of a Non-Clamping Sutureless Technique Combined with Radiofrequency Ultrasound Scalpel in Laparoscopic Nephron-Sparing Surgery for T1 Renal Cell Carcinoma: A Retrospective Cohort Study. Technol Cancer Res Treat Yuan S, Xu S, Mu Y, Che B, Zhai J, Tang K. PMID: 41678385 [PubMed - indexed for MEDLINE]
	FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle Invasive Bladder Cancer. Clin Cancer Res Mirkheshti N, Kpormegbey DE, Weinstock C, Gao X, Pierce WF, Fiero MH, Amiri-Kordestani L, Pazdur R, Suzman DL. PMID: 41678313 [PubMed - as supplied by publisher]
	ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection. Int J Comput Assist Radiol Surg Wilson PFR, Harmanani M, To MNN, Jamzad A, Elghareb T, Guo Z, Kinnaird A, Wodlinger B, Abolmaesumi P, Mousavi P. PMID: 41678064 [PubMed - as supplied by publisher]
	Dynamic 18Â F-PSMA-1007 PET-CT kinetics as a prognostic marker in newly diagnosed prostate cancer: a prospective pilot study. World J Urol Jain TK, Meet P, Punia A, Gupta HL, Dadhich S, Kalani C, Shukla K, Vijay MK, Sharma P, Yadav D, Loyal A, Malhotra H. PMID: 41677920 [PubMed - in process]
	Anatomical refinement matters: ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy. World J Urol Guan B, Peng K, Cao C, Du Y, Zuo W, Han W, Xu C, Zhou L, Li X, Hao H. PMID: 41677900 [PubMed - indexed for MEDLINE]
	Utility of serum biomarkers for prostate cancer diagnosis in the magnetic resonance imaging era. Singapore Med J Wang K, Tsang WC, Wu QH, Chiong E. PMID: 41677411 [PubMed - as supplied by publisher]
	Positive Psychology Interventions in Patients With Prostate Cancer: A Systematic Review. Cancer Rep (Hoboken) Xu E, Phung QH, Runcie K, Liu MA. PMID: 41677086 [PubMed - indexed for MEDLINE]
	No genetic causal links detected between antihypertensive medications and bladder cancer: insights from a trans-ancestry, drug-target Mendelian randomization analysis. Arch Med Sci Xu X, Gu W, Zakeri MA, Chen YH, Hao HY. PMID: 41676414 [PubMed]
	Risk factors for cognitive dysfunction in prostate cancer patients undergoing androgen deprivation therapy: a retrospective study. Am J Transl Res Che Y, Yu X, Qiang P, Che Y, Xu G, Lu D, Liu X, Zhang J, Jiang K. PMID: 41676293 [PubMed]
	Prognostic nutritional index and survival in prostate cancer: an updated systematic review and meta-analysis. Front Nutr Wang G, Wu Q, Chen T. PMID: 41674795 [PubMed]
	Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation Modeling Analysis. medRxiv Kumar P, Alarid-Escudero F, Chiddarwar TV, Garibay-Treviño DU, Chowdhury KR, Peprah P, Jacobs BL, Kuntz KM, Kang SK, Trikalinos TA, Jalal H. PMID: 41674624 [PubMed]

Articles 1 - 20 / 185432

Page 1 of 9272



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy